Clinical Trials Arena on MSN17d
Mixed data results for two Monte Rosa molecular glue degradersMonte Rosa reported that one of its molecular glue degraders had seen a strong response in immune disorders, but another fell short of expectations.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback